What are the pertinent history findings to rule out Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer) in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When evaluating a patient for Lynch syndrome, pertinent history findings include a personal history of colorectal cancer diagnosed before age 50, endometrial cancer before age 50, or multiple Lynch-associated cancers regardless of age, as recommended by the most recent guidelines 1. Pertinent history findings to rule out Lynch syndrome in a patient include:

  • A personal history of colorectal cancer diagnosed before age 50, endometrial cancer before age 50, or multiple Lynch-associated cancers regardless of age
  • Family history of first and second-degree relatives with Lynch-associated cancers, such as colorectal, endometrial, ovarian, gastric, small bowel, urinary tract, biliary tract, pancreatic, brain, and sebaceous gland tumors
  • Pattern of inheritance, with multiple affected family members across generations, indicating an autosomal dominant pattern
  • Tumor characteristics, such as microsatellite instability or loss of mismatch repair protein expression on immunohistochemistry, if testing has been performed
  • Ashkenazi Jewish ancestry or certain founder mutations, which may be relevant in some populations
  • History of multiple colorectal adenomas, typically fewer than 100, distinguishing from familial adenomatous polyposis (FAP) These findings help identify patients who should undergo genetic testing for Lynch syndrome, which involves sequencing of MLH1, MSH2, MSH6, PMS2, and EPCAM genes, as recommended by the National Comprehensive Cancer Network (NCCN) guidelines 1. Early identification allows for enhanced cancer surveillance protocols and preventive interventions for patients and at-risk family members. The use of universal tumor screening for all individuals newly diagnosed with colorectal cancer is also recommended, as it provides a sensitivity of 100% and specificity of 93.0% for identifying individuals with Lynch syndrome 1.

From the Research

History Findings for Ruling Out Lynch Syndrome

To rule out Lynch syndrome in a patient, the following history findings are pertinent:

  • A detailed family history is essential, as Lynch syndrome is a hereditary cancer syndrome 2
  • A history of colorectal or endometrial cancer, as Lynch syndrome accounts for 3% of unselected patients with these cancers 3, 4
  • A history of other cancers associated with Lynch syndrome, such as ovarian cancer, which has a 6-8% risk in women with Lynch syndrome 5
  • Age of diagnosis, as Lynch syndrome-associated cancers often occur at a younger age, with a median age of 49 for endometrial cancer 5
  • Type of cancer, as Lynch syndrome is associated with specific types of cancer, such as endometrioid endometrial cancer and DNA mismatch repair-deficient tumors 3, 5

Key Considerations

When taking a patient's history to rule out Lynch syndrome, consider the following:

  • The patient's personal history of cancer and the age of diagnosis
  • The patient's family history of cancer, including the type of cancer and age of diagnosis
  • The patient's genetic test results, if available, to identify pathogenic variants in genes associated with Lynch syndrome 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.